SCHEMBL1824966

SCHEMBL1824966

Cc1ccc(S(=O)(=O)Oc2cccc(CC(C)NC(=O)c3ccccc3)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.51
GPR17 Q13304 2/20 0.48
ALDH1A1 P00352 3/20 0.48
LMNA P02545 2/20 0.48
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
P2RX7 Q99572 1/20 0.47
CTSL P07711 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
TP53 P04637 1/20 0.47
ACACB O00763 1/20 0.45
MAPT P10636 1/20 0.45
G6PD P11413 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
HPGD P15428 2/20 0.44
ENPP2 Q13822 1/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1824792 0.88 P2RX7 (0.56) GAAALDH1A1LMNANPC1RAB9A
SCHEMBL1826227 0.88 CTSL (0.52) GAAGPR17ALDH1A1LMNAP2RX7
SCHEMBL1828347 0.87 GAA (0.49) GAAGPR17ALDH1A1ACACBMAPT
SCHEMBL1825379 0.86 P2RX7 (0.54) GAAP2RX7CTSL
SCHEMBL1827598 0.83 SIGMAR1 (0.49) GAAGPR17ALDH1A1LMNAMAPT
SCHEMBL1821715 0.82 P2RX7 (0.47) GAAGPR17ALDH1A1LMNAP2RX7
SCHEMBL1825664 0.82 GPR17 (0.51) GAAGPR17ALDH1A1LMNASMN1; SMN2
SCHEMBL1828715 0.80 ALDH1A1 (0.47) GAAALDH1A1LMNANPC1RAB9A
SCHEMBL4599792 0.79 ALDH1A1 (0.47) GAAGPR17ALDH1A1LMNAMAPT
SCHEMBL1824119 0.78 CASP3 (0.42) GAAP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 GAA 2170/4885GPR17 4205/4885ALDH1A1 1099/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 GAA 98/4885GPR17 4459/4885ALDH1A1 1440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.